Published in Vision Res on January 01, 1980
Oxidative damage and age-related macular degeneration. Mol Vis (1999) 2.97
Recent studies provide an updated clinical perspective on blue light-filtering IOLs. Graefes Arch Clin Exp Ophthalmol (2011) 1.51
Violet and blue light blocking intraocular lenses: photoprotection versus photoreception. Br J Ophthalmol (2006) 1.49
How much blue light should an IOL transmit? Br J Ophthalmol (2003) 1.41
Retinal light toxicity. Eye (Lond) (2010) 1.22
Welding arc maculopathy and fluphenazine. Br J Ophthalmol (1991) 1.17
Visual function in patients with yellow tinted intraocular lenses compared with vision in patients with non-tinted intraocular lenses. Br J Ophthalmol (2006) 0.92
Impact of blue-light filtering intraocular lens implantation on the quality of sleep in patients after cataract surgery. Medicine (Baltimore) (2016) 0.84
Chromovitrectomy: update. Saudi J Ophthalmol (2013) 0.79
Endoilluminator phototoxic maculopathy associated with combined ICG-assisted epiretinal membrane and internal limiting membrane peeling. Clin Ophthalmol (2014) 0.77
Aphakic cystoid macular edema and the operating microscope: is there a connection? Trans Am Ophthalmol Soc (1985) 0.76
A perspective on macular degeneration. Bull N Y Acad Med (1983) 0.75
Blue-Light Filtering Spectacle Lenses: Optical and Clinical Performances. PLoS One (2017) 0.75
Blue light hazard and aniridia. Br J Ophthalmol (1985) 0.75
Irradiation of rabbit retina with diode and Nd:YAG lasers. Br J Ophthalmol (1995) 0.75
Trans-spectral organic dye laser photocoagulation. Trans Am Ophthalmol Soc (1985) 0.75
Müller cell alterations from long-term ambient fluorescent light exposure in monkeys: light and electron microscopic, fluorescein and lipofuscin study. Trans Am Ophthalmol Soc (1989) 0.75
Maculopathy following exposure to visible and infrared radiation from a laser pointer: a clinical case study. Doc Ophthalmol (2016) 0.75
Iatrogenic retinal traumas in ophthalmic surgery. Graefes Arch Clin Exp Ophthalmol (2008) 0.75
Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst (1989) 5.28
A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. Hum Pathol (1984) 3.21
Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma. JAMA (1997) 2.65
Retinal sensitivity to damage from short wavelength light. Nature (1976) 2.57
Acquired precursors of cutaneous malignant melanoma. The familial dysplastic nevus syndrome. N Engl J Med (1985) 2.54
Crystal structure of human homogentisate dioxygenase. Nat Struct Biol (2000) 2.16
Survival and quality of life among patients receiving unproven as compared with conventional cancer therapy. N Engl J Med (1991) 1.95
Sensitivity of the retina to radiation damage as a function of wavelength. Photochem Photobiol (1979) 1.90
Optimal resection margin for cutaneous malignant melanoma. Plast Reconstr Surg (1983) 1.89
Characteristics of cultured human melanocytes isolated from different stages of tumor progression. Cancer Res (1985) 1.85
Pneumocystis carinii: growth variables and estimates in the A549 and WI-38 VA13 human cell lines. Exp Parasitol (1985) 1.81
Analysis of the developmental stages of Pneumocystis carinii, in vitro. Lab Invest (1988) 1.79
Incidence of sentinel node metastasis in patients with thin primary melanoma (< or = 1 mm) with vertical growth phase. Ann Surg Oncol (2000) 1.74
The dysplastic nevus syndrome: our definition. Am J Dermatopathol (1982) 1.63
A prognostic model for predicting 10-year survival in patients with primary melanoma. The Pigmented Lesion Group. Ann Intern Med (1996) 1.62
Melanoma of unknown primary site: presentation, treatment, and prognosis--a single institution study. University of Pennsylvania Pigmented Lesion Study Group. Cancer (1997) 1.57
Action spectrum for retinal injury from near-ultraviolet radiation in the aphakic monkey. Am J Ophthalmol (1982) 1.56
In vivo requirement of the alpha-syntrophin PDZ domain for the sarcolemmal localization of nNOS and aquaporin-4. J Cell Biol (2001) 1.51
A randomized clinical trial of granulocyte transfusions for infection in acute leukemia. N Engl J Med (1977) 1.51
Nuclear lamins of erythrocyte and liver. J Biol Chem (1980) 1.47
Histologic analysis of photochemical lesions produced in rhesus retina by short-wave-length light. Invest Ophthalmol Vis Sci (1978) 1.44
Observations on Cogan's microcystic dystrophy of the corneal epithelium. Trans Am Ophthalmol Soc (1965) 1.35
Probit analysis of burn mortality in 1,831 patients: comparison with other large series. Ann Surg (1966) 1.34
Primary melanoma cells of the vertical growth phase: similarities to metastatic cells. J Natl Cancer Inst (1985) 1.30
Proliferation, differentiation, and cytogenetics of chronic leukemic B lymphocytes cultured with mitomycin-treated normal cells. Blood (1981) 1.25
Basic mechanisms underlying the production of photochemical lesions in the mammalian retina. Curr Eye Res (1984) 1.21
Periodic hematopoiesis in human cyclic neutropenia. J Clin Invest (1973) 1.15
Cytogenetics of human malignant melanoma and premalignant lesions. Cancer Genet Cytogenet (1984) 1.15
Potential retinal hazards. Instrument and environmental light sources. Ophthalmology (1983) 1.14
Interaction of glutathione S-transferase M1 and T1 genotypes and malignant melanoma. Cancer Epidemiol Biomarkers Prev (2001) 1.14
Progression-related expression of beta3 integrin in melanomas and nevi. Hum Pathol (1999) 1.13
Precursor naevi in cutaneous malignant melanoma: a proposed nomenclature. Lancet (1980) 1.12
Invasive malignant melanomas lacking competence for metastasis. Am J Dermatopathol (1984) 1.11
Crystal structure and mechanism of a carbon-carbon bond hydrolase. Structure (1999) 1.10
Structural and functional analysis of mutations in alkaptonuria. Hum Mol Genet (2000) 1.10
Factors significantly affecting mortality in the burned patient. J Trauma (1965) 1.09
Congenital orbital teratoma. Arch Ophthalmol (1974) 1.06
WR-2721 and high-dose cisplatin: an active combination in the treatment of metastatic melanoma. J Clin Oncol (1987) 1.06
The early and intermediate precursor lesions of tumor progression in the melanocytic system: common acquired nevi and atypical (dysplastic) nevi. Semin Diagn Pathol (1993) 1.03
Risk of melanoma and other cancers in melanoma-prone families. J Invest Dermatol (1993) 1.02
Dysplastic naevi and cutaneous melanoma risk. Lancet (1983) 0.99
CD4(+), HLA class I-restricted, cytolytic T-lymphocyte clone against primary malignant melanoma cells. Int J Cancer (2000) 0.98
Recombinant gamma-interferon induces changes in expression and shedding of antigens associated with normal human melanocytes, nevus cells, and primary and metastatic melanoma cells. J Immunol (1985) 0.98
Ocular damage thresholds and mechanisms for ultrashort pulses of both visible and infrared laser radiation in the rhesus monkey. Exp Eye Res (1977) 0.98
HLA-DR histocompatibility leukocyte antigens permit cultured human melanoma cells from early but not advanced disease to stimulate autologous lymphocytes. J Clin Invest (1984) 0.97
Screening and surveillance of patients at high risk for malignant melanoma result in detection of earlier disease. J Am Acad Dermatol (1990) 0.97
Retinal burn thresholds for the helium-neon laser in the rhesus monkey. Arch Ophthalmol (1970) 0.96
Concanavalin A-mediated binding and sphering of human red blood cells by homologous monocytes. J Exp Med (1976) 0.96
Ultra high speed electro-optical system for transient birefringence studies of macromolecules in solution. Anal Biochem (1976) 0.95
Cytogenetic evidence for the clonal nature of Richter's syndrome. Blood (1981) 0.93
Chronic neutropenia. Medicine (Baltimore) (1979) 0.93
Effect of cytochalasin B on human monocyte binding and sphering of IgG-coated human erythrocytes. Blood (1977) 0.92
Chromosome 10 allelic loss in malignant melanoma. Genes Chromosomes Cancer (1993) 0.91
Malignant angioendotheliomatosis proliferans treated with doxorubicin. Arch Dermatol (1982) 0.91
Characterization of tenascin secreted by human melanoma cells. Cancer Res (1991) 0.91
Effects of topical tretinoin on dysplastic nevi. J Clin Oncol (1994) 0.91
Dysplastic nevi as risk markers of sporadic (nonfamilial) melanoma. A case-control study. Arch Dermatol (1991) 0.90
An equilibrium thermal model for retinal injury from optical sources. Appl Opt (1969) 0.90
A randomized comparative study of the safety and efficacy of photodynamic therapy using Photofrin II combined with palliative radiotherapy versus palliative radiotherapy alone in patients with inoperable obstructive non-small cell bronchogenic carcinoma. Photochem Photobiol (1987) 0.89
Natural history of dysplastic nevi. J Am Acad Dermatol (1993) 0.89
Production of interleukin 1 activity by cultured human melanoma cells. Cancer Res (1989) 0.89
Interferon-gamma regulates the T cell response to precursor nevi and biologically early melanoma. J Immunol (1987) 0.89
A cohort study of melanoma in patients with dysplastic nevi. J Invest Dermatol (1993) 0.89
Production of multiple cytokines by cultured human melanomas. Exp Dermatol (1993) 0.89
The role of lymph node dissection for clinical stage I malignant melanoma of intermediate thickness (1.51-3.99 mm). Cancer (1985) 0.88
Dysplastic nevi as a melanoma risk factor in patients with familial melanoma. Cancer (1994) 0.88
Locally recurrent malignant melanoma characteristics and outcomes: a single-institution study. Ann Plast Surg (2001) 0.88
MR imaging of intracranial metastatic melanoma. J Comput Assist Tomogr (1987) 0.87
Ocular hazards of light sources: review of current knowledge. J Occup Med (1983) 0.87
Techniques for examining Pneumocystis carinii in fresh specimens. J Clin Microbiol (1986) 0.87
Defective antigen presentation by human melanoma cell lines cultured from advanced, but not biologically early, disease. J Immunol (1989) 0.87
Evaluation of retinal exposures from repetitively pulsed and scanning lasers. Health Phys (1988) 0.85
Photochemical lesions in the primate retina under conditions of elevated blood oxygen. Invest Ophthalmol Vis Sci (1984) 0.85
The use of the laser in neurological surgery. Surg Neurol (1980) 0.85
Lack of association between intraocular melanoma and cutaneous dysplastic nevi. Am J Ophthalmol (1984) 0.84
Mechanisms of retinal damage resulting from the exposure of rhesus monkeys to ultrashort laser pulses. Exp Eye Res (1975) 0.83
Recognition and classification of clinically dysplastic nevi from photographs: a study of interobserver variation. Cancer Epidemiol Biomarkers Prev (1995) 0.83
Remarks on fundus reflectance. Vision Res (1975) 0.83
Early breast cancer: detection of recurrence after conservative surgery and radiation therapy. Radiology (1990) 0.82
Neoplastic progression and prognosis in melanoma. Semin Cutan Med Surg (1996) 0.82
Phenotypic characteristics of cells derived from precursors of human melanoma. Cancer Res (1983) 0.81
Topical chemotherapy of dysplastic melanocytic nevi with 5% fluorouracil. Arch Dermatol (1981) 0.81
Patient and physician delay in melanoma diagnosis. J Am Acad Dermatol (1988) 0.81
Ischemic colitis associated with factor V Leiden mutation. Ann Intern Med (2000) 0.81
Experiences with Light Coagulation of Fundus Lesions. Trans Am Ophthalmol Soc (1959) 0.81